A variety of LncRNAs has emerged as potential biomarkers and therapeutic targets for diverse cardiovascular diseases, such as CHRF, GAS5, MIAT, CARL, MDRL, H19, APF, NRF, and MALAT123. Here, GAS5 is linked to cardiovascular disorder.